PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 10, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
MenopauseCognitive ChangeBrain Disorder, Metabolic
Interventions
DIETARY_SUPPLEMENT

PhytoSERM

PhytoSERM is a dietary supplement containing equal amounts of genistein (16.7 mg ± 10%), daidzein (16.7 mg ± 10%) and S-equol (16.7 mg ± 10%).

DRUG

Placebo

Placebo product with identical shape, size and color will be produced with absence of S-equol, daidzein and genistein. Ingredients include calcium carbonate, comprecel M102, croscarmellose sodium, stearic acid, Zeofree 5162, magnesium stearate, carnauba wax, coating cellulose clear (PEG), coating white (PEG), water.

Trial Locations (1)

10021

RECRUITING

The Alzheimer's Prevention Program / Weill Cornell Medicine, New York

Sponsors
All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

collaborator

Cornell University

OTHER

collaborator

ADM Diagnostics

UNKNOWN

lead

Roberta Brinton

OTHER